AGN Morning Update | 16 April 2025
China-Malaysia relations soar, Meta trial heats up, Korea counters tariffs, Alps drives biotech growth
Malaysia:
President Xi Jinping has arrived in Kuala Lumpur to begin a landmark state visit, aimed at strengthening diplomatic ties and mutual cooperation between China and Malaysia. Xi praised the past 50 years of bilateral relations and hopes to usher in a new “50 golden years” of development and partnership.
International:
Meta CEO Mark Zuckerberg’s testimony at a US antitrust trial revealed Instagram was purchased because it had a “better” product than Facebook’s own. This strengthens FTC allegations that Meta maintained a monopoly through anti-competitive acquisitions. The case could reshape the landscape for Big Tech regulations.
Asia:
South Korea will invest US$4.9 billion into its semiconductor industry through 2026 to mitigate the impact of threatened US tariffs. The plan includes infrastructure and talent development, aiming to secure Korea’s global tech leadership amid rising trade tensions.
Alps Global Holding Berhad:
Alps has signed a strategic MoU with PT Biotis Pharmaceuticals Indonesia, aiming to commercialize vaccines, stem cells, and biosimilars in Malaysia. The deal forms part of RM1.5 billion in biotech investments announced at the 2024 National Bioeconomy Showcase.